Scarica l'app Stockscreener
76.21
4.22%
-3.36
Pre-mercato:
76.49
0.28
+0.37%
Inhibrx Biosciences Inc Azioni (INBX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
100.00%
-
|
0.10 | - | 0.10 | - |
Operating Expenses
|
14.25%
42.90
|
50.03 | 46.80 | 161.00 | 73.83 |
| Operating Income/Loss |
14.07%
-42.90
|
-49.93 | -46.80 | -160.90 | -73.83 |
| Nonoperating Income/Loss |
119.87%
-0.41
|
2.063 | 2.933 | 2,018.91 | -4.885 |
| Income/Loss From Continuing Operations Before Tax |
9.51%
-43.31
|
-47.87 | -43.86 | 1,858.01 | -78.71 |
| Income Tax Expense/Benefit |
-
|
- | - | 0.002 | - |
| Income/Loss From Continuing Operations After Tax |
9.51%
-43.31
|
-47.87 | -43.86 | 1,858.01 | -78.71 |
|
Net Income/Loss
|
9.51%
-43.31
|
-47.87 | -43.86 | 1,858.01 | -78.71 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
6,805%
15.47
|
0.224 | 15.47 | 14.62 | 54.55 |
| Diluted Average Shares |
9,390%
15.47
|
0.163 | 15.47 | 14.81 | 54.55 |
| Basic Earnings Per Share |
44.33%
-2.80
|
-5.03 | -2.84 | 127.10 | -1.44 |
| Diluted Earnings Per Share |
37.36%
-2.80
|
-4.47 | -2.84 | 125.48 | -1.44 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):